GlassScriptPhysician profile
David N Carlson
NPI 1891003125
$5,968.87
in general payments reported to CMS, 2019-2025
18 companies · $847 in 2025
The $847 reported for 2025 was more than what 78% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,656 · 2020: $689 · 2021: $471 · 2022: $203 · 2023: $409 · 2024: $694 · 2025: $847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756 · Consulting Fee: $160 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,755.63 |
| Consulting Fee | $160.00 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $2,572.40 | 2019-2020 | |
| Inspire Medical Systems, INC. | $1,733.00 | 2020-2025 | Inspire |
| Medtronic, INC. | $496.84 | 2021-2025 | Stealthstation S8 Platform, Straightshot, Surgipro Ll |
| Aerin Medical INC. | $216.69 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $214.97 | 2019-2025 | Dupixent |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Smith+Nephew, INC. | $103.44 | 2019-2025 | Tula |
| Optinose US, INC. | $97.41 | 2019-2022 | |
| Glaxosmithkline, LLC. | $73.56 | 2021-2025 | Nucala |
| Genzyme Corporation | $62.73 | 2019-2025 | |
| Acclarent, INC | $58.29 | 2020-2021 | |
| Amgen INC. | $53.04 | 2025 | Tezspire |
| Ambu INC. | $27.96 | 2020-2023 | |
| Acell, INC. | $24.45 | 2019 | |
| Cochlear Americas | $24.18 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $23.22 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Stryker Corporation | $20.62 | 2025 | Audion Et Dilation System |
| Pacira Pharmaceuticals Incorporated | $16.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.